DCV20 Pill - yellow & white capsule/oblong
Generic Name: vimseltinib
Pill with imprint DCV20 is Yellow & White, Capsule/Oblong and has been identified as Romvimza 20 mg. It is supplied by Deciphera Pharmaceuticals, LLC.
Romvimza is used in the treatment of Tenosynovial Giant Cell Tumor and belongs to the drug class miscellaneous antineoplastics. Romvimza 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DCV20
Romvimza
- Generic Name
- vimseltinib
- Imprint
- DCV20
- Strength
- 20 mg
- Color
- Yellow & White (white body and yellow cap)
- Shape
- Capsule/Oblong (hard gelatin capsule)
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Deciphera Pharmaceuticals, LLC
- National Drug Code (NDC)
- 73207-0303
More about Romvimza (vimseltinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.